Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report
Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Myriad Genetics, Inc. (Myriad or 'the company') is a molecular diagnostic company. The company is engaged in the development and marketing of novel predictive medicine, personalized medicine and prognostic medicine products. The company operates in the US and Europe. It is headquartered in Salt Lake City, Utah.
Detailed information on Myriad Genetics, Inc. required for business and competitor intelligence needs.
A study of the major internal and external factors affecting Myriad Genetics, Inc. in the form of a SWOT analysis.
An in-depth view of the business model of Myriad Genetics, Inc. including a breakdown and examination of key business segments.
Intelligence on Myriad Genetics, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors.
News about Myriad Genetics, Inc., such as business expansion, restructuring, and contract wins.
Large number of easy-to-grasp charts and graphs that present important data and key trends.
Reasons to buy
Gain understanding of Myriad Genetics, Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Myriad Genetics, Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Myriad Genetics, Inc.'s business structure, strategy and prospects.